Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name pulmonext by MSN labs ) is a drug indicated for use in the treatment of pulmonary hypertension.It functions as an endothelin receptor antagonist and is selective for the type A endothelin receptor (ETA).
This page contains content from the copyrighted Wikipedia article "Ambrisentan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
